Bharat Biotech’s COVAXIN becomes 1st indegenous vaccine approved by WHO
COVAXIN is approved for Emergency Use Listing. WHO's approval will open travel channels to several countries.
The World Health Organisation has cleared India made Covaxin for an emergency use listing after a process that lasted several months. The Covid 19 vaccine made by Hyderabad based Bharat Biotech and which has been administered to lakhs of Indians was pending approval from the World Health Organisation without which several major nations had also not yet recognised the vaccine. Covaxin has been cleared for use in 18+ age groups over two doses spaced four weeks apart. Dr Krishna Ella, Chairman and Managing Director, Bharat Biotech, called it as a significant step by WHO. The WHO Emergency Use Listing Procedure (EUL) authorisation for Covaxin will enable Bharat Biotech to contribute to accelerating the equitable access of Covid-19 vaccine, and the access to the indigenous vaccine globally thereby addressing the current public health emergency, the MD said in a company statement.